Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Roth P et al. – SC68896 is the first proteasome inhibitor that exerts antiglioma activity in vivo. It may represent a novel prototype agent for the treatment of malignant gliomas and warrants clinical evaluation.

Related Articles

Identification of anti-prothrombin antibodies in the anti-phospholipid syndrome that display the prothrombinase activity
Rheumatology, 11/20/09    Relevance Score: 47%

Long-term and recent recreational physical activity and survival after breast cancer: The California Teachers Study
Cancer Epidemiology, Biomarkers & Prevention, 10/26/09    Relevance Score: 47%

Intensity and timing of physical activity in relation to postmenopausal breast cancer risk: the prospective NIH-AARP Diet and Health Study
BMC Cancer, 10/05/09    Relevance Score: 47%

Gender and age-specific seasonal variations in physical activity among adults
Journal of Epidemiology and Community Health, 10/29/09    Relevance Score: 46%

DNase1 activity in systemic lupus erythematosus patients with and without nephropathy
Rheumatology International, 10/26/09    Relevance Score: 46%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address